Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients

Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients

A Jayaprakash Patil1,2,3, Ashish Sharma1,4, M Cristina Kenney1, Baruch D Kuppermann11Department of Ophthalmology, Gavin S Herbert Eye Institute, University of California, Irvine, Irvine, CA, USA; 2Department of Ophthalmology, Summa Health System, Akron, OH, USA; 3Northeastern Ohio Universities Colle...

Full description

Bibliographic Details
Main Authors:	A Jayaprakash Patil, Ashish Sharma, M Cristina Kenney, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2010-03-01
Series:	Clinical Ophthalmology
Online Access:	http://www.dovepress.com/valganciclovir-in-the-treatment-of-cytomegalovirus-retinitis-in-hiv-in-a4021

Similar Items

Valganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplantation
by: Erin Wade Ticehurst, et al.
Published: (2010-03-01)

Cytomegalovirus retinitis treated with valganciclovir in Wegener&rsquo;s granulomatosis
by: Kabata Y, et al.
Published: (2012-03-01)

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients
by: Doesch AO, et al.
Published: (2012-10-01)

A succinct synthesis of valganciclovir hydrochloride – A cytomegalovirus (CMV) retinitis inhibitor
by: Karrothu Srihari Babu
Published: (2011-01-01)

Onset of valganciclovir resistance in two infants with congenital cytomegalovirus infection
by: Francesca Garofoli, et al.
Published: (2020-09-01)

Treatment of unilateral zone I cytomegalovirus retinitis in acute lymphoblastic leukemia with oral valganciclovir and intravitreal ganciclovir
by: Koushik Tripathy, et al.
Published: (2017-01-01)

Unexpected hearing improvement after treatment with valganciclovir in a child with congenital cytomegalovirus infection
by: Silvia Palma, et al.
Published: (2021-04-01)

Efficacy of Low Dose Valganciclovir Prophylaxis for Cytomegalovirus Infection in Kidney Transplantation
by: Ümit Özçelik, et al.
Published: (2020-01-01)

Refractory ulcerative colitis complicated by cytomegalovirus infection successfully treated with valganciclovir
by: Tiziana Larussa, et al.
Published: (2012-11-01)

Treatment of Retinal Separation in HIV-infected Patients with Cytomegalovirus Retinitis
by: A. L. Onischenko, et al.
Published: (2017-03-01)

Assessment of mitochondrial toxicity in newborns and infants with congenital cytomegalovirus infection treated with valganciclovir
by: Cantó-Santos, J., et al.
Published: (2022)

Efficacy of Valganciclovir Treatment Depends on the Severity of Hearing Dysfunction in Symptomatic Infants with Congenital Cytomegalovirus Infection
by: Shohei Ohyama, et al.
Published: (2019-03-01)

Long-term results of oral valganciclovir for treatment of anterior segment inflammation secondary to cytomegalovirus infection
by: Wong VW, et al.
Published: (2012-04-01)

Letermovir for Cytomegalovirus Prophylaxis in Lung Transplant Patients with Valganciclovir-Induced Leukopenia
by: Arindam Singha, et al.
Published: (2021-04-01)

Role of oral valganciclovir in sick preterm with cytomegalovirus virus infection and ventilation dependence
by: Anumodan Gupta, et al.
Published: (2019-01-01)

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients.
by: Jong Man Kim, et al.
Published: (2015-01-01)

Valganciclovir for cytomegalovirus preemptive therapy in patients following allogeneic hematopoietic stem cell transplantation
by: LU Xuan, et al.
Published: (2020-09-01)

Treating HIV-associated cytomegalovirus retinitis with oral valganciclovir and intra-ocular ganciclovir by primary HIV clinicians in southern Myanmar: a retrospective analysis of routinely collected data
by: Jillian Murray, et al.
Published: (2020-11-01)

Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy.
by: Andre C Kalil, et al.
Published: (2009-01-01)

Clinical Features of Cytomegalovirus Retinitis in HIV Infected Patients
by: Yang Tang, et al.
Published: (2020-04-01)

Treatment of cytomegalovirus anterior segment infection with intravitreal injection of ganciclovir in adjunction with or without oral valganciclovir: a long-term results
by: Yu-Chun Cheng, et al.
Published: (2021-02-01)

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis
by: Siavash Vaziri, et al.
Published: (2014-01-01)

High efficacy and low toxicity of short-course oral valganciclovir as pre-emptive therapy for hematopoietic stem cell transplant cytomegalovirus infection
by: A.J.M. Saleh, et al.
Published: (2010-07-01)

Long-Term Clinical, Audiological, Visual, Neurocognitive and Behavioral Outcome in Children With Symptomatic and Asymptomatic Congenital Cytomegalovirus Infection Treated With Valganciclovir
by: Arianna Turriziani Colonna, et al.
Published: (2020-07-01)

Cytomegalovirus prophylaxis using low-dose valganciclovir in patients with acute leukemia undergoing allogeneic hematopoietic stem-cell transplantation
by: Po-Hsien Li, et al.
Published: (2021-03-01)

Treatment of cytomegalovirus retinitis
by: B. S. Pershin, et al.
Published: (2019-11-01)

Non-healing vulval ulcer in an immunocompromised female due to concurrent Herpes Simplex Virus and Cytomegalovirus co-infection treated effectively with Valganciclovir
by: Preema Sinha, et al.
Published: (2020-01-01)

Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients
by: Buclin Thierry, et al.
Published: (2010-01-01)

Cytomegalovirus Retinitis in HIV and Non-HIV Individuals
by: Monique Munro, et al.
Published: (2019-12-01)

Evaluation of alternate-day valganciclovir prophylaxis for cytomegalovirus disease prevention in moderate risk renal transplant patients: A retrospective observational study
by: Puneet Bhuwania, et al.
Published: (2021-01-01)

Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma
by: Pantalone, M.R, et al.
Published: (2022)

Chronic Human Herpes Virus 8 Infection Successfully Treated With Valganciclovir
by: James J. Yun, MBBS, et al.
Published: (2009-01-01)

Cytomegalovirus in renal transplant recipients from living donors with and without valganciclovir prophylaxis and with immunosuppression based on anti-thymocyte globulin or basiliximab
by: Jorge Andrade-Sierra, et al.
Published: (2021-06-01)

Effectiveness of Valganciclovir 900mg Versus 450mg for Cytomegalovirus Prophylaxis in Renal Transplantation: A Systematic Review and Meta-Analysis
by: wang xin, et al.
Published: (2017-07-01)

Effects of hydroquinone on retinal and vascular cells in vitro
by: Ashish Sharma, et al.
Published: (2012-01-01)

Valganciclovir as Add-On to Standard Therapy in Secondary Glioblastoma
by: Giuseppe Stragliotto, et al.
Published: (2020-09-01)

Cytomegalovirus and paediatric HIV infection
by: J.e.n.n.i.f.e.r.A. Slyker
Published: (2016-10-01)

Cytomegalovirus uveitis in HIV-infected patients: course and outcomes
by: T. D. Sizova, et al.
Published: (2020-10-01)

Dataset of aqueous humor cytokine profile in HIV patients with Cytomegalovirus (CMV) retinitis
by: Jayant Venkatramani Iyer, et al.
Published: (2016-09-01)

Development of an appropriate simple suspension method for valganciclovir medication
by: Yasuyuki Masaoka, et al.
Published: (2020-07-01)